Emergex Vaccines

About:

Pioneering a new approach to vaccine development and manufacturing using cutting-edge technologies to produce novel synthetic vaccines.

Website: https://emergexvaccines.com/

Twitter/X: emergexvaccines

Top Investors: Innovate UK, Vickers Venture Partners, Trend Investment Group, Department of Health and Social Care (DHSC)

Description:

Emergex Vaccines offer affordable, practical and effective vaccines on-demand, which are suited to low resource environments, disproportionately affected by pandemics. These vaccines will be used to create a clinical grade international vaccine repository that will act as a first line of defence in the case of existing and newly emerging infectious disease outbreaks.

Total Funding Amount:

$13M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Abingdon, Oxfordshire, United Kingdom

Founded Date:

2016-01-01

Founders:

Thomas Rademacher

Number of Employees:

11-50

Last Funding Date:

2022-02-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai